Editors Choice Articles: SGLT2 inhibitors in frailty, multimorbidity and polypharmacy; SGLT2 inhibitors and cardiovascular death; and mobile health technology in CKD management
2024/9/23
Clinical Journal of the American Society of Nephrology (CJASN)
Shownotes Transcript
No transcript made for this episode yet, you may request it for free.